Sean Maduck Corcept Therapeutics Inc (CORT) insider trading activity

Sean Maduck is of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 7,681 shares of CORT, which is worth approximately $565,244. The most recent transaction as insider was on Nov 10, 2022, when has been sold 25,000 shares (Common Stock) at a price of $25.57 per share, resulting in proceeds of $639,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.68K

91.03% 3M change

90.9% 12M change

Total Value Held $565,244

Sean Maduck Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 10 2022	SELL Open market or private sale	$639,250 $25.57 p/Share	25,000 Reduced 30.69%	56,462 Common Stock
Nov 10 2022	BUY Exercise of conversion of derivative security	$82,250 $3.29 p/Share	25,000 Added 23.48%	81,462 Common Stock
Oct 03 2022	SELL Open market or private sale	$641,000 $25.64 p/Share	25,000 Reduced 30.69%	56,462 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	$82,250 $3.29 p/Share	25,000 Added 23.48%	81,462 Common Stock
Sep 01 2022	SELL Bona fide gift	-	922 Reduced 2.25%	40,106 Common Stock
Sep 01 2022	SELL Open market or private sale	$646,000 $25.84 p/Share	25,000 Reduced 31.4%	54,618 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	$82,250 $3.29 p/Share	25,000 Added 23.9%	79,618 Common Stock
Sep 01 2022	BUY Grant, award, or other acquisition	$23,954 $12.99 p/Share	1,844 Added 3.16%	56,462 Common Stock
Aug 19 2022	SELL Bona fide gift	-	14,594 Reduced 26.24%	41,028 Common Stock
Aug 19 2022	SELL Payment of exercise price or tax liability	$11,206 $27.6 p/Share	406 Reduced 0.74%	54,618 Common Stock
Aug 19 2022	BUY Exercise of conversion of derivative security	$33,600 $2.24 p/Share	15,000 Added 21.42%	55,024 Common Stock
Aug 12 2022	SELL Exercise of conversion of derivative security	$711,760 $28.7 p/Share	24,800 Reduced 38.26%	40,024 Common Stock
Aug 12 2022	BUY Exercise of conversion of derivative security	$64,728 $2.61 p/Share	24,800 Added 27.67%	64,824 Common Stock
Aug 09 2022	SELL Open market or private sale	$5,740 $28.7 p/Share	200 Reduced 0.5%	40,024 Common Stock
Aug 09 2022	BUY Exercise of conversion of derivative security	$384 $1.92 p/Share	200 Added 0.49%	40,224 Common Stock
Jul 18 2022	SELL Open market or private sale	$684,250 $27.37 p/Share	25,000 Reduced 38.45%	40,024 Common Stock
Jul 18 2022	BUY Exercise of conversion of derivative security	$50,000 $2.0 p/Share	25,000 Added 27.77%	65,024 Common Stock
Oct 05 2021	SELL Open market or private sale	$12,740 $20.0 p/Share	637 Reduced 1.57%	40,024 Common Stock
Oct 05 2021	BUY Exercise of conversion of derivative security	$2,096 $3.29 p/Share	637 Added 1.54%	40,661 Common Stock
Oct 01 2021	SELL Open market or private sale	$487,260 $20.0 p/Share	24,363 Reduced 37.84%	40,024 Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$80,154 $3.29 p/Share	24,363 Added 27.45%	64,387 Common Stock
Sep 01 2021	SELL Open market or private sale	$535,000 $21.4 p/Share	25,000 Reduced 38.45%	40,024 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$82,250 $3.29 p/Share	25,000 Added 27.77%	65,024 Common Stock
Aug 03 2021	SELL Open market or private sale	$529,500 $21.18 p/Share	25,000 Reduced 38.45%	40,024 Common Stock
Aug 03 2021	BUY Exercise of conversion of derivative security	$82,250 $3.29 p/Share	25,000 Added 27.77%	65,024 Common Stock

Sean Maduck

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Value

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT

Account